A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
暂无分享，去创建一个
A. Iasonos | C. Aghajanian | K. Cadoo | W. Tew | Hongmei Xu | D. Zamarin | R. O’Cearbhaill | V. Makker | R. Grisham | I. Nikolovski | C. Friedman | Madhuri Martin | C. Kyi | Qin C Zhou | M. Rubinstein | Joyce Guillen | Krysten Soldan | Imogen Caird | K. Eid